L-arginine prevents corticotropin-induced increases in blood pressure in the rat

Hypertension

Volumn 27, Issue 2, 1996, Pages 184-189

  Turner, Steven W ^a   Wen, Cheng ^a   Li, Ming ^a   Whitworth, Judith A ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

adrenocorticotropic hormone; arginine; blood pressure; corticosterone; hypertension, experimental; rats

Indexed keywords

ARGININE; CORTICOSTERONE; CORTICOTROPIN; DEXTRO ARGININE; ELECTROLYTE; POTASSIUM; SODIUM; SODIUM CHLORIDE; TETRACOSACTIDE ZINC PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE EXCRETION; FLUID INTAKE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE; URINE VOLUME;

EID: 0030059645     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.2.184     Document Type: Article

References (27)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothclium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Marletta MA. Nitric oxide: biosynthesis and biological significance, Trends Biochem Sci. 1989;14:488-492.
4. G-methyl arginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun. 1989;160:881-886.
5. Rees DD, Palmer RM, Moncada S. Role of endolhelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
6. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S, Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990;15:486-492.
7. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
8. Vazir H, Whitehouse BJ, Vinson GP, McCredie E. Effects of prolonged ACTH treatment on adrenal steroidogencsis and blood pressure in rats. Acta Endocrinol Copenh. 1981;97:533-542.
9. Whitworth JA, Hewitson TD, Ming L, Wilson RS, Scoggins BA, Wright RD, Kincaid-Smith P. Adrenocorticotrophin-induced hypertension in the rat: hemodynamic, metabolic and morphological characteristics. J Hypertens. 1990;8:27-36.
10. Whitworth JA, Hewitson TD, Cornwallis C. Corticotrophin effects on blood pressure and fluid and electrolyte homeostasis in five strains of rats. Am J Hypertens. 1992;5:302-313.
11. Li M, Dusting GJ, Whitworth JA, Inhibition of NO synthesis has an additive effect on hypertension induced by ACTH in conscious rats. Clin Exp Pharmacol Physiol. 1992;19:675-681.
12. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A. 1990;87:10043-10047.
13. G-nitro-L-arginine and comparisons to alcohol. Life Sci. 1991;50:35-40.
14. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
15. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
16. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol. 1990;1:875-881.
17. Kirchner KA, Scanlon PH, Dzielak DJ, Hester RL. Endothelium-derived relaxing factor responses in DOCA-salt hypertensive rats. Am J Physiol. 1993;265:R568-R572.
18. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kalo R. L-arginine-induced hypotension. Lancet. 1990;336:696. Letter.
19. Cernadas MR, Riesco A, Gallego MJ, Grandes S, Lopez Farre A, Casado S, Hernando L, Caramelo C. L-arginine-induced hypotension. Lancet. 1990;336:1016-1017.
20. Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. L-arginine-induced hypotension. Lancet. 1991;337:683-684.
21. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci. 1991;81:695-700.
22. Palacios M, Knowles RG, Palmer RM, Moncada S. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun. 1989;165:802-809.
23. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension. 1993;22:812-818.
24. Dananberg J, Sider RS, Grekin RJ. Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension. 1993;21:359-363.
25. Linder D, Kiowski W, Buhler FR, Luschcr TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation. 1990;81:1762-1767.
26. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
27. Esplugues JV, Martinez-Cuesta MA, Barrachina MD, Calatayud S, Whittle BJR. Involvement of endogenous nitric oxide in the inhibition by endotoxin and interleukin-1β of gastric acid secretion. J Gastroenterol Hepatol. 1994;9:S45-S49.